{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T15:59:02Z","timestamp":1780761542437,"version":"3.54.1"},"reference-count":80,"publisher":"Elsevier","isbn-type":[{"value":"9780443415470","type":"print"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/bs.apha.2026.02.003","type":"book-chapter","created":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T12:32:20Z","timestamp":1772022740000},"page":"133-170","source":"Crossref","is-referenced-by-count":0,"title":["Chemically enhanced brain shuttle peptides"],"prefix":"10.1016","author":[{"given":"Cristina","family":"D\u00edaz-Perlas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"MAR","key":"10.1016\/bs.apha.2026.02.003_bib1","article-title":"Designing and characterization of a novel delivery system for improved cellular uptake by brain using dendronised Apo-E-derived peptide","volume":"7","author":"Al-azzawi","year":"2019","journal-title":"Frontiers in Bioengineering and Biotechnology"},{"issue":"1","key":"10.1016\/bs.apha.2026.02.003_bib2","doi-asserted-by":"crossref","first-page":"6446","DOI":"10.1038\/s41598-018-24517-6","article-title":"Immunosilencing peptides by stereochemical inversion and sequence reversal: Retro-D-peptides","volume":"8","author":"Arranz-Gibert","year":"2018","journal-title":"Scientific Reports"},{"issue":"1","key":"10.1016\/bs.apha.2026.02.003_bib3","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-35938-8","article-title":"HAI peptide and backbone analogs\u2014Validation and enhancement of biostability and bioactivity of BBB shuttles","volume":"8","author":"Arranz-Gibert","year":"2018","journal-title":"Scientific Reports"},{"issue":"7","key":"10.1016\/bs.apha.2026.02.003_bib4","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1093\/emboj\/19.7.1525","article-title":"Identification of a peptide blocking vascular endothelial growth factor (VEGF)-mediated angiogenesis","volume":"19","author":"Bin\u00e9 Truy-Tournaire","year":"2000","journal-title":"The EMBO Journal"},{"issue":"2","key":"10.1016\/bs.apha.2026.02.003_bib5","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1021\/acsanm.0c02888","article-title":"Amphiphilic polymeric nanoparticles modified with a protease-resistant peptide shuttle for the delivery of SN-38 in diffuse intrinsic pontine glioma","volume":"4","author":"Bukchin","year":"2021","journal-title":"ACS Applied Nano Materials"},{"issue":"1","key":"10.1016\/bs.apha.2026.02.003_bib6","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12987-024-00545-5","article-title":"Molecular determinants for brain targeting by peptides: A meta-analysis approach with experimental validation","volume":"21","author":"Cavaco","year":"2024","journal-title":"Fluids and Barriers of the CNS"},{"issue":"11","key":"10.1016\/bs.apha.2026.02.003_bib7","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1021\/acsmedchemlett.1c00225","article-title":"Conjugation of a blood brain barrier peptide shuttle to an Fc domain for brain delivery of therapeutic biomolecules","volume":"12","author":"Cavaco","year":"2021","journal-title":"ACS Medicinal Chemistry Letters"},{"issue":"6","key":"10.1016\/bs.apha.2026.02.003_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0099733","article-title":"A stable and reproducible human blood-brain barrier model derived from hematopoietic stem cells","volume":"9","author":"Cecchelli","year":"2014","journal-title":"PLoS One"},{"issue":"45","key":"10.1016\/bs.apha.2026.02.003_bib9","doi-asserted-by":"crossref","first-page":"41889","DOI":"10.1021\/acsami.9b14046","article-title":"Blood-brain barrier- and blood-brain tumor barrier-penetrating peptide-derived targeted therapeutics for glioma and malignant tumor brain metastases","volume":"11","author":"Chen","year":"2019","journal-title":"ACS Applied Materials and Interfaces"},{"issue":"7","key":"10.1016\/bs.apha.2026.02.003_bib10","doi-asserted-by":"crossref","first-page":"636","DOI":"10.2174\/1389201017666160401144440","article-title":"Synergistic combination of doxorubicin and paclitaxel delivered by blood brain barrier and glioma cells dual targeting liposomes for chemotherapy of brain glioma","volume":"17","author":"Chen","year":"2016","journal-title":"Current Pharmaceutical Biotechnology"},{"key":"10.1016\/bs.apha.2026.02.003_bib11","article-title":"BBPpredict: A web service for identifying blood-brain barrier penetrating peptides","volume":"13","author":"Chen","year":"2022","journal-title":"Frontiers in Genetics"},{"issue":"4","key":"10.1016\/bs.apha.2026.02.003_bib12","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1111\/j.1471-4159.2008.05492.x","article-title":"Involvement of the low-density lipoprotein receptor-related protein in the transcytosis of the brain delivery vector Angiopep-2","volume":"106","author":"Demeule","year":"2008","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/bs.apha.2026.02.003_bib13","doi-asserted-by":"crossref","first-page":"8409","DOI":"10.1039\/C8SC02415D","article-title":"Branched BBB-shuttle peptides: Chemoselective modification of proteins to enhance blood-brain barrier transport","volume":"9","author":"D\u00edaz-Perlas","year":"2018","journal-title":"Chemical Science"},{"issue":"1","key":"10.1016\/bs.apha.2026.02.003_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/bip.22928","article-title":"Phage display as a tool to discover blood\u2013brain barrier (BBB)-shuttle peptides: Panning against a human BBB cellular model","volume":"108","author":"D\u00edaz-Perlas","year":"2017","journal-title":"Biopolymers"},{"issue":"90","key":"10.1016\/bs.apha.2026.02.003_bib15","doi-asserted-by":"crossref","first-page":"12738","DOI":"10.1039\/C8CC06725B","article-title":"From venoms to BBB-shuttles. MiniCTX3: A molecular vector derived from scorpion venom","volume":"54","author":"D\u00edaz-Perlas","year":"2018","journal-title":"Chemical Communications"},{"key":"10.1016\/bs.apha.2026.02.003_bib16","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jconrel.2017.02.006","article-title":"Recent developments in anticancer drug delivery using cell penetrating and tumor targeting peptides","volume":"250","author":"Dissanayake","year":"2017","journal-title":"Journal of Controlled Release"},{"issue":"1","key":"10.1016\/bs.apha.2026.02.003_bib17","doi-asserted-by":"crossref","DOI":"10.1093\/noajnl\/vdae186","article-title":"Phase II trial of blood\u2013brain barrier permeable peptide-paclitaxel conjugate ANG1005 in patients with recurrent high-grade glioma","volume":"6","author":"Dmello","year":"2024","journal-title":"Neuro-Oncology Advances"},{"issue":"1","key":"10.1016\/bs.apha.2026.02.003_bib18","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1080\/10717544.2021.1968977","article-title":"Brain-targeting delivery of MMB4 DMS using carrier-free nanomedicine CRT-MMB4@MDZ","volume":"28","author":"Du","year":"2021","journal-title":"Drug Delivery"},{"key":"10.1016\/bs.apha.2026.02.003_bib19","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.addr.2020.10.001","article-title":"Designing peptide nanoparticles for efficient brain delivery","volume":"160","author":"Duro-Castano","year":"2020","journal-title":"Advanced Drug Delivery Reviews"},{"issue":"8","key":"10.1016\/bs.apha.2026.02.003_bib20","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1016\/j.bmc.2018.03.009","article-title":"Fine-tuning the physicochemical properties of peptide-based blood\u2013brain barrier shuttles","volume":"26","author":"Ghasemy","year":"2018","journal-title":"Bioorganic and Medicinal Chemistry"},{"issue":"2","key":"10.1016\/bs.apha.2026.02.003_bib21","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1021\/acs.molpharmaceut.8b01216","article-title":"Short peptide-mediated brain-targeted drug delivery with enhanced immunocompatibility","volume":"16","author":"Guan","year":"2019","journal-title":"Molecular Pharmaceutics"},{"key":"10.1016\/bs.apha.2026.02.003_bib22","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/psc.2900","article-title":"Chemically synthesized peptide libraries as a new source of BBB shuttles. Use of mass spectrometry for peptide identification","author":"Guixer","year":"2016","journal-title":"Journal of Peptide Science"},{"issue":"5","key":"10.1016\/bs.apha.2026.02.003_bib23","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.1021\/acsbiomaterials.3c01622","article-title":"RVG29 peptide-modified exosomes loaded with Mir-133b mediate the RhoA-ROCK pathway to improve motor and neurological symptoms in Parkinson\u2019s disease","volume":"10","author":"Jiang","year":"2024","journal-title":"ACS Biomaterials Science and Engineering"},{"issue":"9","key":"10.1016\/bs.apha.2026.02.003_bib24","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.3390\/polym12091906","article-title":"iRGD peptide as a tumor-penetrating enhancer for tumor-targeted drug delivery","volume":"12","author":"Kang","year":"2020","journal-title":"Polymers"},{"issue":"7","key":"10.1016\/bs.apha.2026.02.003_bib25","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1046\/j.1432-1327.2001.02073.x","article-title":"Receptor mediated uptake of peptides that bind the human transferrin receptor","volume":"268","author":"Lee","year":"2001","journal-title":"European Journal of Biochemistry"},{"issue":"4","key":"10.1016\/bs.apha.2026.02.003_bib26","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1039\/C7TB02450A","article-title":"Iron-mimic peptide converts transferrin from foe to friend for orally targeting insulin delivery","volume":"6","author":"Liu","year":"2018","journal-title":"Journal of Materials Chemistry B"},{"issue":"1","key":"10.1016\/bs.apha.2026.02.003_bib27","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.2147\/IJN.S61288","article-title":"Current approaches to enhance CNS delivery of drugs across the brain barriers","volume":"9","author":"Lu","year":"2014","journal-title":"International Journal of Nanomedicine"},{"issue":"12","key":"10.1016\/bs.apha.2026.02.003_bib28","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.3390\/pharmaceutics13122065","article-title":"Protease\u2010resistant peptides for targeting and intracellular delivery of therapeutics","volume":"13","author":"Lucana","year":"2021","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/bs.apha.2026.02.003_bib29","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1039\/D3CB00194F","article-title":"BrainBike peptidomimetic enables efficient transport of proteins across brain endothelium","volume":"5","author":"Lucana","year":"2023","journal-title":"RSC Chemical Biology"},{"key":"10.1016\/bs.apha.2026.02.003_bib30","article-title":"Development of simplified, photo-active, and TfR1-targeted poly(\u03b2-aminoester)-zwitterion nanovehicles for gene delivery across brain endothelium","author":"Lucana","year":"2025","journal-title":"Drug Delivery and Translational Research"},{"key":"10.1016\/bs.apha.2026.02.003_bib31","doi-asserted-by":"crossref","first-page":"3477","DOI":"10.1007\/s13346-024-01585-y","article-title":"Nucleic acid-loaded poly(beta-aminoester) nanoparticles for cancer nano-immuno therapeutics: the good, the bad, and the future","volume":"14","author":"Maga\u00f1a Rodriguez","year":"2024","journal-title":"Drug Delivery and Translational Research"},{"issue":"6","key":"10.1016\/bs.apha.2026.02.003_bib32","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1021\/jm901654x","article-title":"N-Methyl phenylalanine-rich peptides as highly versatile blood-brain barrier shuttles","volume":"53","author":"Malakoutikhah","year":"2010","journal-title":"Journal of Medicinal Chemistry"},{"issue":"35","key":"10.1016\/bs.apha.2026.02.003_bib33","doi-asserted-by":"crossref","first-page":"7998","DOI":"10.1002\/anie.201006565","article-title":"Shuttle-mediated drug delivery to the brain","volume":"50","author":"Malakoutikhah","year":"2011","journal-title":"Angewandte Chemie - International Edition"},{"key":"10.1016\/bs.apha.2026.02.003_bib34","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1021\/acs.molpharmaceut.4c01091","article-title":"A site-specific MiniAp4-Trastuzumab conjugate prevents brain metastasis","volume":"22","author":"Masmudi-Mart\u00edn","year":"2025","journal-title":"Molecular Pharmaceutics"},{"key":"10.1016\/bs.apha.2026.02.003_bib35","doi-asserted-by":"crossref","DOI":"10.1038\/srep36617","article-title":"PEPlife: A repository of the half-life of peptides","volume":"6","author":"Mathur","year":"2016","journal-title":"Scientific Reports"},{"issue":"6 June","key":"10.1016\/bs.apha.2026.02.003_bib36","article-title":"Comparison of polypeptides that bind the transferrin receptor for targeting gold nanocarriers","volume":"16","author":"McQuaid","year":"2021","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/bs.apha.2026.02.003_bib37","doi-asserted-by":"crossref","first-page":"8583","DOI":"10.1021\/nn402662d","article-title":"Cyclic RGD-linked polymeric micelles for targeted delivery of platinum anticancer drugs to glioblastoma through the blood-brain tumor barrier","volume":"7","author":"Miura","year":"2013","journal-title":"ACS Nano"},{"key":"10.1016\/bs.apha.2026.02.003_bib38","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1093\/oxfordjournals.jbchem.a021431","article-title":"Novel peptide ligands for integrin alpha 6 beta 1 selected from a phage display library 1","volume":"120","author":"Murayama","year":"1996","journal-title":"Journal of Biochemistry"},{"issue":"7","key":"10.1016\/bs.apha.2026.02.003_bib39","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1517\/17425247.2013.762354","article-title":"Drug targeting to brain: A systematic approach to study the factors, parameters and approaches for prediction of permeability of drugs across BBB","volume":"10","author":"Nagpal","year":"2013","journal-title":"Expert Opinion on Drug Delivery"},{"issue":"3","key":"10.1016\/bs.apha.2026.02.003_bib40","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1074\/jbc.M116.759837","article-title":"An L- to D-amino acid conversion in an endosomolytic analog of the cell-penetrating peptide TAT influences proteolytic stability, endocytic uptake, and endosomal escape","volume":"292","author":"Najjar","year":"2017","journal-title":"Journal of Biological Chemistry"},{"issue":"5","key":"10.1016\/bs.apha.2026.02.003_bib41","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1021\/acschembio.7b00087","article-title":"Novel peptides derived from dengue virus capsid protein translocate reversibly the blood-brain barrier through a receptor-free mechanism","volume":"12","author":"Neves","year":"2017","journal-title":"ACS Chemical Biology"},{"key":"10.1016\/bs.apha.2026.02.003_bib42","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/anie.201508445","article-title":"MiniAp-4: A venom-inspired peptidomimetic for brain delivery","volume":"55","author":"Oller-Salvia","year":"2016","journal-title":"Angewandte Chemie - International Edition"},{"issue":"17","key":"10.1016\/bs.apha.2026.02.003_bib43","doi-asserted-by":"crossref","first-page":"4690","DOI":"10.1039\/C6CS00076B","article-title":"Blood-brain barrier shuttle peptides: An emerging paradigm for brain delivery","volume":"45","author":"Oller-Salvia","year":"2016","journal-title":"Chemical Society Reviews"},{"issue":"2","key":"10.1016\/bs.apha.2026.02.003_bib44","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nrd725","article-title":"Drug and gene targeting to the brain with molecular Trojan horses","volume":"1","author":"Pardridge","year":"2002","journal-title":"Nature Reviews. Drug Discovery"},{"issue":"11","key":"10.1016\/bs.apha.2026.02.003_bib45","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1038\/jcbfm.2012.126","article-title":"Drug transport across the blood-brain barrier","volume":"32","author":"Pardridge","year":"2012","journal-title":"Journal of Cerebral Blood Flow and Metabolism"},{"issue":"12","key":"10.1016\/bs.apha.2026.02.003_bib46","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1021\/acs.bioconjchem.3c00446","article-title":"Brain-penetrating peptide shuttles across the blood-brain barrier and extracellular-like space","volume":"34","author":"Peng","year":"2023","journal-title":"Bioconjugate Chemistry"},{"key":"10.1016\/bs.apha.2026.02.003_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2025.115637","article-title":"A new era in brain drug delivery: Integrating multivalency and computational optimisation for blood\u2013brain barrier permeation","volume":"224","author":"Porro","year":"2025","journal-title":"Advanced Drug Delivery Reviews"},{"issue":"13","key":"10.1016\/bs.apha.2026.02.003_bib48","doi-asserted-by":"crossref","first-page":"3967","DOI":"10.1002\/anie.201411408","article-title":"Applying the retro-enantio approach to obtain a peptide capable of overcoming the blood-brain barrier","volume":"54","author":"Prades","year":"2015","journal-title":"Angewandte Chemie - International Edition"},{"key":"10.1016\/bs.apha.2026.02.003_bib49","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1021\/acs.molpharmaceut.4c01327","article-title":"New trends in brain shuttle peptides","volume":"22","author":"Prades","year":"2025","journal-title":"Molecular Pharmaceutics"},{"key":"10.1016\/bs.apha.2026.02.003_bib50","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jconrel.2017.03.037","article-title":"GRP78 enabled micelle-based glioma targeted drug delivery","volume":"255","author":"Ran","year":"2017","journal-title":"Journal of Controlled Release"},{"issue":"2","key":"10.1016\/bs.apha.2026.02.003_bib51","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/bjp.2008.260","article-title":"Antitumour activity of ANG1005, a conjugate between paclitaxel and the new brain delivery vector Angiopep-2","volume":"155","author":"R\u00e9gina","year":"2008","journal-title":"British Journal of Pharmacology"},{"issue":"2","key":"10.1016\/bs.apha.2026.02.003_bib52","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1021\/acs.molpharmaceut.7b00944","article-title":"A d -Peptide ligand of integrins for simultaneously targeting angiogenic blood vasculature and glioma cells","volume":"15","author":"Ren","year":"2018","journal-title":"Molecular Pharmaceutics"},{"key":"10.1016\/bs.apha.2026.02.003_bib53","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.jconrel.2018.04.035","article-title":"A novel peptide ligand RAP12 of LRP1 for glioma targeted drug delivery","volume":"279","author":"Ruan","year":"2018","journal-title":"Journal of Controlled Release"},{"issue":"12","key":"10.1016\/bs.apha.2026.02.003_bib54","first-page":"198","article-title":"Enhanced proton treatment with a LDLR-ligand peptide-conjugated gold nanoparticles targeting the tumor microenvironment in an infiltrative brain tumor model","volume":"12","author":"Seo","year":"2022","journal-title":"American Journal of Cancer Research"},{"key":"10.1016\/bs.apha.2026.02.003_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2023.109637","article-title":"Uncovering CNS access of lipidated exendin-4 analogues by quantitative whole-brain 3D light sheet imaging","volume":"238","author":"Skovbjerg","year":"2023","journal-title":"Neuropharmacology"},{"issue":"18","key":"10.1016\/bs.apha.2026.02.003_bib56","doi-asserted-by":"crossref","first-page":"7594","DOI":"10.1073\/pnas.0702170104","article-title":"Targeted delivery of proteins across the blood-brain barrier","volume":"104","author":"Spencer","year":"2007","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"6","key":"10.1016\/bs.apha.2026.02.003_bib57","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/j.1399-3011.2005.00254.x","article-title":"Abbreviated nomenclature for cyclic and branched homo- and hetero-detic peptides","volume":"65","author":"Spengler","year":"2005","journal-title":"Journal of Peptide Research"},{"issue":"6\u20137","key":"10.1016\/bs.apha.2026.02.003_bib58","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1002\/prca.200900213","article-title":"Combinatorial vascular targeting in translational medicine","volume":"4","author":"Staquicini","year":"2010","journal-title":"Proteomics. Clinical Applications"},{"issue":"1","key":"10.1016\/bs.apha.2026.02.003_bib59","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1172\/JCI44798","article-title":"Systemic combinatorial peptide selection yields a non-canonical iron-mimicry mechanism for targeting tumors in a mouse model of human glioblastoma","volume":"121","author":"Staquicini","year":"2011","journal-title":"Journal of Clinical Investigation"},{"issue":"3","key":"10.1016\/bs.apha.2026.02.003_bib60","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1007\/s00216-017-0664-4","article-title":"Selection and identification of transferrin receptor-specific peptides as recognition probes for cancer cells","volume":"410","author":"Tan","year":"2018","journal-title":"Analytical and Bioanalytical Chemistry"},{"issue":"10","key":"10.1016\/bs.apha.2026.02.003_bib61","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1177\/0271678X18772998","article-title":"A peptide derived from melanotransferrin delivers a protein-based interleukin 1 receptor antagonist across the BBB and ameliorates neuropathic pain in a preclinical model","volume":"39","author":"Thom","year":"2019","journal-title":"Journal of Cerebral Blood Flow and Metabolism"},{"key":"10.1016\/bs.apha.2026.02.003_bib62","doi-asserted-by":"crossref","first-page":"4397","DOI":"10.1126\/sciadv.abc4397","article-title":"On the shuttling across the blood-brain barrier via tubule formation: Mechanism and cargo avidity bias","volume":"6","author":"Tian","year":"2020","journal-title":"Science Advances"},{"issue":"3","key":"10.1016\/bs.apha.2026.02.003_bib63","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.jconrel.2010.11.004","article-title":"Endosomal escape pathways for delivery of biologicals","volume":"151","author":"Varkouhi","year":"2011","journal-title":"Journal of Controlled Release"},{"issue":"8","key":"10.1016\/bs.apha.2026.02.003_bib64","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1073\/pnas.1222742110","article-title":"Engineering a lysosomal enzyme with a derivative of receptor-binding domain of apoE enables delivery across the blood-brain barrier","volume":"110","author":"Wang","year":"2013","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"10","key":"10.1016\/bs.apha.2026.02.003_bib65","doi-asserted-by":"crossref","first-page":"3261","DOI":"10.1021\/mp500086e","article-title":"Retro-inverso isomer of angiopep-2: A stable d -peptide ligand inspires brain-targeted drug delivery","volume":"11","author":"Wei","year":"2014","journal-title":"Molecular Pharmaceutics"},{"issue":"10","key":"10.1016\/bs.apha.2026.02.003_bib66","doi-asserted-by":"crossref","first-page":"3023","DOI":"10.1002\/anie.201411226","article-title":"A D-peptide ligand of nicotine acetylcholine receptors for brain-targeted drug delivery","volume":"54","author":"Wei","year":"2015","journal-title":"Angewandte Chemie - International Edition"},{"key":"10.1016\/bs.apha.2026.02.003_bib67","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.addr.2020.11.010","article-title":"A quantitative view on multivalent nanomedicine targeting","volume":"169","author":"Woythe","year":"2021","journal-title":"Advanced Drug Delivery Reviews"},{"issue":"1","key":"10.1016\/bs.apha.2026.02.003_bib68","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/s41392-021-00724-y","article-title":"Retro-enantio isomer of angiopep-2 assists nanoprobes across the blood-brain barrier for targeted magnetic resonance\/fluorescence imaging of glioblastoma","volume":"6","author":"Xie","year":"2021","journal-title":"Signal Transduction and Targeted Therapy"},{"key":"10.1016\/bs.apha.2026.02.003_bib69","doi-asserted-by":"crossref","first-page":"5755","DOI":"10.2147\/IJN.S318266","article-title":"Efficient anti-glioma therapy through the brain-targeted RVG15-modified liposomes loading paclitaxel-cholesterol complex","volume":"16","author":"Xin","year":"2021","journal-title":"International Journal of Nanomedicine"},{"issue":"1","key":"10.1016\/bs.apha.2026.02.003_bib70","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1186\/s12951-021-00997-z","article-title":"RVG-functionalized reduction sensitive micelles for the effective accumulation of doxorubicin in brain","volume":"19","author":"Xu","year":"2021","journal-title":"Journal of Nanobiotechnology"},{"key":"10.1016\/bs.apha.2026.02.003_bib71","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.jconrel.2020.03.001","article-title":"Novel cyclic peptides facilitating transcellular blood-brain barrier transport of macromolecules in vitro and in vivo","volume":"321","author":"Yamaguchi","year":"2020","journal-title":"Journal of Controlled Release"},{"key":"10.1016\/bs.apha.2026.02.003_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116737","article-title":"Efficient systemic CNS delivery of a therapeutic antisense oligonucleotide with a blood-brain barrier-penetrating ApoE-derived peptide","volume":"175","author":"Yeoh","year":"2024","journal-title":"Biomedicine and Pharmacotherapy"},{"issue":"21","key":"10.1016\/bs.apha.2026.02.003_bib73","doi-asserted-by":"crossref","first-page":"13232","DOI":"10.1021\/acsami.6b01300","article-title":"Stabilized heptapeptide A7R for enhanced multifunctional liposome-based tumor-targeted drug delivery","volume":"8","author":"Ying","year":"2016","journal-title":"ACS Applied Materials and Interfaces"},{"key":"10.1016\/bs.apha.2026.02.003_bib74","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jconrel.2016.09.035","article-title":"A stabilized peptide ligand for multifunctional glioma targeted drug delivery","volume":"243","author":"Ying","year":"2016","journal-title":"Journal of Controlled Release"},{"issue":"23","key":"10.1016\/bs.apha.2026.02.003_bib75","doi-asserted-by":"crossref","first-page":"19473","DOI":"10.1021\/acsami.8b05235","article-title":"Myristic acid-modified DA7R peptide for whole-process glioma-targeted drug delivery","volume":"10","author":"Ying","year":"2018","journal-title":"ACS Applied Materials and Interfaces"},{"issue":"1","key":"10.1016\/bs.apha.2026.02.003_bib76","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1021\/acsami.8b16219","article-title":"D-T7 Peptide-modified PEGylated bilirubin nanoparticles loaded with cediranib and paclitaxel for antiangiogenesis and chemotherapy of glioma","volume":"11","author":"Yu","year":"2019","journal-title":"ACS Applied Materials and Interfaces"},{"issue":"24","key":"10.1016\/bs.apha.2026.02.003_bib77","doi-asserted-by":"crossref","first-page":"5596","DOI":"10.1002\/ange.201100875","article-title":"Micelle\u2010based brain\u2010targeted drug delivery enabled by a nicotine acetylcholine receptor ligand","volume":"123","author":"Zhan","year":"2011","journal-title":"Angewandte Chemie"},{"issue":"10","key":"10.1016\/bs.apha.2026.02.003_bib78","doi-asserted-by":"crossref","first-page":"9094","DOI":"10.1021\/acsami.7b16096","article-title":"Ligand size and conformation affect the behavior of nanoparticles coated with in vitro and in vivo protein corona","volume":"10","author":"Zhang","year":"2018","journal-title":"ACS Applied Materials and Interfaces"},{"issue":"6","key":"10.1016\/bs.apha.2026.02.003_bib79","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1021\/acs.molpharmaceut.8b00270","article-title":"Enhanced glioblastoma targeting ability of carfilzomib enabled by a D A7R-modified lipid nanodisk","volume":"15","author":"Zhang","year":"2018","journal-title":"Molecular Pharmaceutics"},{"key":"10.1016\/bs.apha.2026.02.003_bib80","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2018.03.025","article-title":"Highly efficacious and specific anti-glioma chemotherapy by tandem nanomicelles co-functionalized with brain tumor-targeting and cell-penetrating peptides","volume":"278","author":"Zhu","year":"2018","journal-title":"Journal of Controlled Release"}],"container-title":["Advances in Pharmacology","Brain Shuttle Peptides: Development and Applications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1054358926000207?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1054358926000207?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T14:58:51Z","timestamp":1780757931000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1054358926000207"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9780443415470"],"references-count":80,"URL":"https:\/\/doi.org\/10.1016\/bs.apha.2026.02.003","relation":{},"ISSN":["1054-3589"],"issn-type":[{"value":"1054-3589","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]}}}